Effects of long term ethanol consumption mediated oxidative stress on neovessel generation in liver

Toxicology Mechanisms and Methods

Volumn 22, Issue 5, 2012, Pages 375-382

  Das, Subir Kumar ^a   Mukherjee, Sukhes ^b   Vasudevan, D M ^b  

^a WBUHS   (India)

^b AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Ethanol; matrix metalloproteinases; oxidative stress; vascular endothelial growth factor receptor; von Willebrand factor

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; INTERLEUKIN 1; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR;

ALCOHOL CONSUMPTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; LIVER REGENERATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CELL HYPOXIA; CYTOKINES; ETHANOL; FIBROSIS; LIVER; LIVER DISEASES, ALCOHOLIC; LIVER FUNCTION TESTS; MALE; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; RATS; RATS, WISTAR; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VON WILLEBRAND FACTOR;

RATTUS;

EID: 84860865386     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.666651     Document Type: Article

References (58)

1. Ambili M, Jayasree K, Sudhakaran PR. 1998. 60K gelatinase involved in mammary gland involution is regulated by β-oestradiol. Biochim Biophys Acta 1403:219-231. (Pubitemid 28451563)
2. Arteel GE, Iimuro Y, Yin M, Raleigh JA, Thurman RG. 1997. Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo. Hepatology 25:920-926. (Pubitemid 27157135)
3. Bardag-Gorce F, French BA, Li J, Riley NE, Yuan QX, Valinluck V, Fu P, Ingelman-Sundberg M, Yoon S, French SW. 2002. The importance of cycling of blood alcohol levels in the pathogenesis of experimental alcoholic liver disease in rats. Gastroenterology 123: 325-335. (Pubitemid 34747552)
4. Baruch Y, Neubauer K, Ritzel A, Wilfling T, Lorf T, Ramadori G. 2004. Von Willebrand gene expression in damaged human liver. Hepatogastroenterology 51:684-688. (Pubitemid 38590941)
5. Beutler E, Duron O, Kelly BM. 1963. Improved method for the determination of blood glutathione. J Lab Clin Med 61:882-888.
6. Carmeliet P. 2003. Angiogenesis in health and disease. Nat Med 9:653-660. (Pubitemid 36749213)
7. Chedid A, Arain S, Snyder A, Mathurin P, Capron F, Naveau S. 2004. The immunology of fibrogenesis in alcoholic liver disease. Arch Pathol Lab Med 128:1230-1238. (Pubitemid 39441644)
8. Choi DY, Baek YH, Huh JE, Ko JM, Woo H, Lee JD, Park DS. 2009. Stimulatory effect of Cinnamomum cassia and cinnamic acid on angiogenesis through up-regulation of VEGF and Flk-1/KDR expression. Int Immunopharmacol 9:959-967.
9. Cohen JI, Nagy LE. 2011. Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells. J Dig Dis 12:3-9.
10. Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J. 2006. Cytokines and alcohol. Alcohol Clin Exp Res 30:720-730.
11. Das SK, Dhanya L, Varadhan S, Mukherjee S, Vasudevan DM. 2009a. Effects of chronic ethanol consumption in blood: a time dependent study on rat. Indian J Clin Biochem 24:301-306.
12. Das SK, Mukherjee S, Vasudevan DM. 2010. Effects of long-term ethanol consumption on adhesion molecules in liver. Indian J Exp Biol 48:394-401.
13. Das SK, Varadhan S, Gupta G, Mukherjee S, Dhanya L, Rao DN, Vasudevan DM. 2009b. Time-dependent effects of ethanol on blood oxidative stress parameters and cytokines. Indian J Biochem Biophys 46:116-121.
14. Das SK, Vasudevan DM. 2005. Effect of ethanol on liver antioxidant defense systems: a dose dependent study. Indian J Clin Biochem 20:80-84. (Pubitemid 40363609)
15. Das SK, Vasudevan DM. 2006b. Protective effects of silymarin, a milk thistle (Silybium marianum) derivative on ethanol-induced oxidative stress in liver. Indian J Biochem Biophys 43:306-311.
16. Das SK, Vasudevan DM. 2007. Essential factors associated with hepatic angiogenesis. Life Sciences 81:1555-1564. (Pubitemid 350116201)
17. Dufour JF, Clavien PA. 2010 In: Signaling Pathways in Liver Diseases, 2nd edition, Berlin Heidelberg: Springer-Verlag, 425.
18. Fausto N. 2000. Liver regeneration. J Hepatol 32:19-31. (Pubitemid 30123621)
19. Fernández-Checa JC, Kaplowitz N, Colell A, García-Ruiz C. 1997. Oxidative stress and alcoholic liver disease. Alcohol Health Res World 21:321-324. (Pubitemid 127709918)
20. Fortunato F, Berger I, Gross ML, Rieger P, Buechler MW, Werner J. 2007. Immune-compromised state in the rat pancreas after chronic alcohol exposure: the role of peroxisome proliferator-activated receptor gamma. J Pathol 213:441-452. (Pubitemid 350214249)
21. Friedman SL. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247-2250. (Pubitemid 30081976)
22. Gabbita SP, Robinson KA, Stewart CA, Floyd RA, Hensley K. 2000. Redox regulatory mechanisms of cellular signal transduction. Arch Biochem Biophys 376:1-13. (Pubitemid 30205109)
23. García-Monzón C, Sánchez-Madrid F, García-Buey L, García-Arroyo A, García-Sánchez A, Moreno-Otero R. 1995. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 108:231-241.
24. Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130-7139.
25. Hill DB, D'Souza NB, Lee EY, Burikhanov R, Deaciuc IV, de Villiers WJ. 2002. A role for interleukin-10 in alcohol-induced liver sensitization to bacterial lipopolysaccharide. Alcohol Clin Exp Res 26:74-82. (Pubitemid 34093514)
26. Iyer S, Scotney PD, Nash AD, Ravi Acharya K. 2006. Crystal structure of human vascular endothelial growth factor-B: identification of amino acids important for receptor binding. J Mol Biol 359:76-85.
27. Kono Y, Fridovich I. 1982. Superoxide radical inhibits catalase. J Biol Chem 257:5751-5754.
28. Lelkes PI, Hahn KL, Sukovich DA, Karmiol S, Schmidt DH. 1998. On the possible role of reactive oxygen species in angiogenesis. Adv Exp Med Biol 454:295-310. (Pubitemid 29005542)
29. Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. 2006. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 44:53-61. (Pubitemid 44049138)
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
31. Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amore PA. 2006. Vascular endothelial growth factor localization in the adult. Am J Pathol 168:639-648. (Pubitemid 43271161)
32. Matsuyama T, Uemura M, Ishikawa M, Matsumoto M, Ishizashi H, Kato S, Morioka C, Fujimoto M, Kojima H, Yoshiji H, Takimura C, Fujimura Y, Fukui H. 2007. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis. Alcohol Clin Exp Res 31:S27-S35.
33. Mazurier C, Ribba AS, Gaucher C, Meyer D. 1998. Molecular genetics of von Willebrand disease. Ann Genet 41:34-43. (Pubitemid 28185043)
34. McCuskey RS, Reilly FD. 1993. Hepatic microvasculature: dynamic structure and its regulation. Semin Liver Dis 13:1-12. (Pubitemid 23119807)
35. Medina J, Arroyo AG, Sánchez-Madrid F, Moreno-Otero R. 2004. Angiogenesis in chronic inflammatory liver disease. Hepatology 39:1185-1195. (Pubitemid 38569038)
36. Mehendale HM. 2005. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol 33:41-51. (Pubitemid 40216803)
37. Moriga T, Arii S, Takeda Y, Furuyama H, Mizumoto M, Mori A, Hanaki K, Nakamura T, Fujioka M, Imamura M. 2000. Protection by vascular endothelial growth factor against sinusoidal endothelial damage and apoptosis induced by cold preservation. Transplantation 69:141-147. (Pubitemid 30062621)
38. Nanji AA, Tahan SR, Golding M, Khwaja S, Rahemtulla A, Lalani EN. 1996. Role of transforming growth factor-[β]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease. Am J Pathol 148:739-747. (Pubitemid 126660667)
39. Namiecinska M, Marciniak K, Nowak JZ. 2005. [VEGF as an angiogenic, neurotrophic, and neuroprotective factor]. Postepy Hig Med Dosw (Online) 59:573-583.
40. Norrby K. 1997. Angiogenesis: new aspects relating to its initiation and control. APMIS 105:417-437. (Pubitemid 27314455)
41. Paglia DE, Valentine WN. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169.
42. Paoletti F, Aldinucci D, Mocali A, Caparrini A. 1986. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 154:536-541. (Pubitemid 16075292)
43. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladstone SR, Friedman M, Sellke FW, Simons M. 1995. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med 1:1085-1089.
44. Pinto RE, Bartley W. 1969. The effect of age and sex on glutathione reductase and glutathione peroxidase activities and on aerobic glutathione oxidation in rat liver homogenates. Biochem J 112:109-115.
45. Plaa GL, Witschi H. 1976. Chemicals, drugs, and lipid peroxidation. Annu Rev Pharmacol Toxicol 16:125-141.
46. Qin L, He J, Hanes RN, Pluzarev O, Hong JS, Crews FT. 2008. Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. J Neuroinflammation 5:10.
47. Radek KA, Kovacs EJ, Gallo RL, DiPietro LA. 2008. Acute ethanol exposure disrupts VEGF receptor cell signaling in endothelial cells. Am J Physiol Heart Circ Physiol 295:H174-H184.
48. Sarphie G, D'Souza NB, Van Thiel DH, Hill D, McClain CJ, Deaciuc IV. 1997. Dose- and time-dependent effects of ethanol on functional and structural aspects of the liver sinusoid in the mouse. Alcohol Clin Exp Res 21:1128-1136. (Pubitemid 27407180)
49. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. 2001. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 21: 351-372. (Pubitemid 32923765)
50. Shih SC, Mullen A, Abrams K, Mukhopadhyay D, Claffey KP. 1999. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells. J Biol Chem 274:15407-15414.
51. Sinnhuber RO, Yu TC, Yu TC. 1958. Characterization of the red pigment formed in the thiobarbituric acid determination of oxidative rancidity. Food Res, 23, 626-630.
52. Tan W, Bailey AP, Shparago M, Busby B, Covington J, Johnson JW, Young E, Gu JW. 2007. Chronic alcohol consumption stimulates VEGF expression, tumor angiogenesis and progression of melanoma in mice. Cancer Biol Ther 6:1211-1217. (Pubitemid 351590374)
53. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. 2001. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 49:121-130.
54. van Hinsbergh VW, Engelse MA, Quax PH. 2006. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 26:716-728. (Pubitemid 43732143)
55. Videla LA, Iturriaga H, Pino ME, Bunout D, Valenzuela A, Ugarte G. 1984. Content of hepatic reduced glutathione in chronic alcoholic patients: influence of the length of abstinence and liver necrosis. Clin Sci 66:283-290. (Pubitemid 14187492)
56. Vogten JM, Drixler TA, te Velde EA, Schipper ME, van Vroonhoven TJ, Voest EE, Borel Rinkes IH. 2004. Angiostatin inhibits experimental liver fibrosis in mice. Int J Colorectal Dis 19:387-394. (Pubitemid 38868307)
57. Yano S, Matsumori Y, Ikuta K, Ogino H, Doljinsuren T, Sone S. 2006. Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancer. Int J Clin Oncol 11:73-81.
58. Zhang YP, Yao XX, Zhao X. 2006. Interleukin-1 β up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells. World J Gastroenterol 12:1392-1396.